STAT Plus: Novartis’ experimental cardiovascular drug fails a pivotal study STAT 3d Novartis Pharma Science
STAT Plus: After failure of Angelman syndrome drug, experts see hope in other experimental therapies STAT 3d Pharma
Ionis chalks up CNS win as FDA greenlights Zanvastro in Alexander disease BioWorld 3d Pharma Article paywall
